Multicancer screening blood test trialled in women
26 tumours were picked up in nearly 10,000 tests
A multicancer blood test appears to have met its initial goal of being an effective addition to standard screening for cancer, in a study of nearly 10,000 women.
The new tool, a multi-analyte blood test called DETECT-A, relies on DNA and protein biomarkers, Dr Kenneth Kinzler of Johns Hopkins University School of Medicine, in Baltimore, US, and colleagues explain in Science.
